Roel De Alejandro

Evaluate the quality of search results and provide constructive feedback to organization. Assess how well content meets a user's search request, and evaluate the quality of results based on the expertise, authoritativeness, and trustworthiness of the content.

Lead sales and marketing teams in cultivating deep relationships with physicians, medical clinics, hospital systems, attorneys, and patients. Drive strategic growth and brand awareness for Alamo City Pharmacy, Tricity Pain Associates, Phase 4 Physiotherapy, and associated ambulatory surgery centers (ASCs).

Actively engage national/regional payors and physician practices on negotiation and implementation of value-based care arrangements to increase revenue, membership and reduce costs. Guide the go-to-market strategy for partnering with high-value providers in on adoption of health tech, virtual resources, Acumen EHR and value-based care agreements. Provide leadership to cross functional teams.

Engaged with strategic importance and established credibility with key, national account Leadership as well as internal stakeholders in Marketing and Commercial Operations to drive corporate/national account imperatives. Demonstrated expertise on reimbursement dynamics and communicated impact on provider revenue stream and clinical impact.Led team of Area Managers to ensure clinical expertise.

Responsible for Business Development and access of innovative equipment/technologies for Peritoneal Dialysis (PD), In-Center dialysis (IHD), Continuous Renal Replacement Therapy (CRRT), multi-organ extracorporeal support therapy and additional dialysis services. Provided direction to team of Clinical Specialists, Therapy Development Specialists, and Implementation Specialists.

Promoted breakthrough medical technology, first ever non-invasive total hemoglobin, spot-test diagnostic device to PCPs, Pediatrics, OB/GYN, Nephrology, Cardiology, Gastroenterology, Hematology, Oncology and Pulmonology specialties. Demonstrated expertise on Medicaid, Medicare and commercial insurance dynamics within multiple clinic sites.

Launched Fosrenol for hyperphosphatemia, fostered relationships with regional KOLs and increased business in a Renal specialty market which included San Antonio, Laredo, Corpus Christi and the Rio Grande Valley area Nephrologists, key members of the Renal care team and dialysis centers, IDNs and the VA/DOD. Established superior clinical acumen of disease state and built credibility with care team.

Directed the value-based care transition with national payor/provider partnerships to position the organization for risk-aligned leadership. Secured $6M in strategic capital, onboarded 500+ providers, transitioned 1,500+ lives into risk-sharing models, and helped deliver a 3% total cost-of-care reduction.

Accelerated regional commercial velocity to achieve a #1 national ranking in Q1 2020. Delivered $4.1M in incremental revenue in one month and increased quarterly revenue by $7.35M, while scaling home therapies and remote patient monitoring adoption by 47% YoY.

Led regional business development for advanced dialysis and extracorporeal therapies across academic medical centers, IDNs, and VA/DoD systems. Launched the PrisMax AKI/CRRT platform with 15 units in the first 60 days and grew territory revenue to $15.1M (104% of goal), including a 117% YoY increase in SGP via the Amia APD System.

Earned a Bachelor of Science in Health Administration from Texas A&M University.